Solid pharmaceutical dosage form for release of at least one active pharmaceutical ingredient in the oral cavity

A solid pharmaceutical dosage form comprising:

• a. a core, wherein the core comprises at least one Active Pharmaceutical Ingredient (API) and at least one additional component, wherein the core comprises a weight of from about 50 mg to about 2000 mg, wherein the at least one API is selected from the group consisting of anesthetics, antibiotics, anti-inflammatory drugs, anti-migraine drugs, anti-diarrheas, antiseptics, decongestants, erectile dysfunction drugs, mucolytics, muscle relaxants, anti-allergy drugs, substances for the treatment of malodour, expectorants and cough suppressants, and
• b. at least one film coating, wherein the at least one film coating comprises at least one film-forming polymer, at least one flavoring agent and at least one sweetener,
• wherein the solid pharmaceutical dosage form is selected from the group consisting of a lozenge, a sublingual tablet, a buccal tablet and an orally disintegrating tablet,
• wherein the solid pharmaceutical dosage form does not contain nicotine,
• wherein upon administration, the at least one API is capable of being completely dissolved in the oral cavity, and
• wherein one or more organoleptically disturbing sensations induced by one or more of the at least one API and/or of the at least one additional component is/are reduced by the at least one flavouring agent and the at least one sweetener.